Costal cartilage ossification and bone aging with special reference to the clinical significance

肋软骨骨化与骨老化特别参考的临床意义

基本信息

  • 批准号:
    63570707
  • 负责人:
  • 金额:
    $ 1.34万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1988
  • 资助国家:
    日本
  • 起止时间:
    1988 至 1989
  • 项目状态:
    已结题

项目摘要

1) Control study : Radiographs of the costal cartilages were examined in 253 control patients( 140 males and 113 females, 10-90 years ). The costal cartilage ossification ( CCO ) was classified into tree categories ; type I ( marginal ), type II ( central ), type III ( other ). This typing was found very useful as an indicator of sexing ; 97% cases of type I were male, and 98% of type II were female. We classified the degree of CCO into three; grade I ( less than 1/3 of costal cartilage length ), grade II ( 1/3 to 2/3 ), and grade III ( more than 2/3 ). The ossification rate and degree increased with aging, and those in female were rapider than in male. 2) Histological study ( 26 autopsied cases ): the endochondral ossification was observed in all the types of CCO. By energy-dispersive X-ray analysis with scanning electron micros copy, hydroxyapatite crystal was clarified. 3)Relationship with pathological conditions a) Osteoporosis : 58 patients were compared with 89 age-matched controls, and found that the rate and degree of CCO was statistically smaller. b) Knee meniscus calcification : 13 patients were compared with 89 age-matched controls, and found that those of CCO had no statistical difference. c) Ossification of spinal ligament: 28 patients were compared with 127 age-matched controls, and found that those of CCO was statistically larger. 4) Quantitative CT study showed that the more Ca in bone, the larger CCO. As a conclusion, CCO seemed to be a good indicator for sexing and bone quantity.
1)对照研究:对253例对照患者(男140例,女113例,年龄10~90岁)进行肋软骨X线片检查。肋软骨骨化(CCO)分为三型:I型(边缘型)、II型(中央型)、III型(其他)。这种分型被发现作为性别鉴定的指标非常有用;I型病例中97%是男性,II型病例中98%是女性。我们将CCO的程度分为三级:I级(小于肋软骨长度的1/3),II级(1/3~2/3),III级(大于2/3)。骨化率和骨化程度随年龄增长而增加,且女性快于男性。2)组织学观察(26例尸检):各型CCO均可见软骨内骨化。通过X射线能谱分析和扫描电子显微镜分析,明确了羟基磷灰石的晶体结构。3)骨质疏松症与病理条件的关系:58例患者与89例年龄匹配的对照组比较,发现CCO的发生率和程度均有统计学意义。B)膝关节半月板钙化:13例患者与89例年龄匹配的对照组比较,发现CCO患者的半月板钙化程度无统计学差异。C)脊柱韧带骨化:28例患者与127例年龄匹配的对照组比较,发现CCO的骨化程度有统计学意义。4)定量CT研究显示,骨中钙含量越高,CCO越大。综上所述,CCO似乎是性别划分和骨量的良好指标。

项目成果

期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
飯塚正: "脊柱靱帯骨化症における肋軟骨骨化について" 厚生省特定疾患昭和62年度報告書. 35-37 (1988)
Tadashi Iizuka:“关于脊柱韧带骨化中的软骨骨化”厚生省 1988 年特定疾病报告 35-37 (1988)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
飯塚正: 関東整形災害外科学会誌.
饭冢正:关东骨科杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Iizuka, Tadashi et al: "Bome aging and ossification of costal cartilage; special reference to osteoporosis." Orthop Surg Traumatol 32 : 1523-1527, 1987.
Iizuka, Tadashi 等人:“Bome 老化和肋软骨骨化;特别提及骨质疏松症。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Iizuka, Tadashi et al: "Clinical significance of costal cartilage ossification." J Jpn Orthop Assoc 62 : s.1288, 1988.
Iizuka, Tadashi 等人:“肋软骨骨化的临床意义。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
飯塚正: 関東整形災害外科学会誌. 18. 590-593 (1987)
饭冢正:关东整形外科学会杂志 18. 590-593 (1987)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

IIZUKA Tadashi其他文献

IIZUKA Tadashi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('IIZUKA Tadashi', 18)}}的其他基金

Isolation of mesenchymal stem cells for induction of dental hard tissue from rat gingiva.
分离间充质干细胞以诱导大鼠牙龈中的牙齿硬组织。
  • 批准号:
    23659908
  • 财政年份:
    2011
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research

相似海外基金

The diagnosis and treatment of postoperative bone mineral density decrease after spine surgery
脊柱术后骨密度下降的诊治
  • 批准号:
    23K15697
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Determining Bone Loss and Bone Mineral Density Recovery Following Repeat Pregnancy/Lactation Among HIV Women on ART
确定接受 ART 治疗的 HIV 妇女重复怀孕/哺乳后的骨质流失和骨矿物质密度恢复情况
  • 批准号:
    10805834
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Study of the relationship between resistance training and bone mineral density and bone quality using an ultrasonic bone measurement system
使用超声波骨测量系统研究阻力训练与骨矿物质密度和骨质量之间的关系
  • 批准号:
    23K10699
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
DDTBMQ000054: Regulatory qualification for DXA bone mineral density as a surrogate endpoint for fracture risk in osteoporosis trials
DDTBMQ000054:DXA 骨矿物质密度作为骨质疏松症试验中骨折风险替代终点的监管资格
  • 批准号:
    10623740
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
The influence of irisin/FNDC5 on bone mineral density and fracture risk in individuals with spinal cord injury
鸢尾素/FNDC5对脊髓损伤个体骨矿物质密度和骨折风险的影响
  • 批准号:
    10609491
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Minimising bone mineral density loss in traumatic amputees: a randomised controlled feasibility trial
最大限度地减少创伤性截肢者的骨矿物质密度损失:一项随机对照可行性试验
  • 批准号:
    EP/X027155/1
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Fellowship
Functional Dissection of the MARK3 GWAS Locus for Bone Mineral Density
MARK3 GWAS 基因座骨矿物质密度的功能剖析
  • 批准号:
    10260104
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Functional Dissection of the MARK3 GWAS Locus for Bone Mineral Density
MARK3 GWAS 基因座骨矿物质密度的功能剖析
  • 批准号:
    10512047
  • 财政年份:
    2021
  • 资助金额:
    $ 1.34万
  • 项目类别:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Romosozumab 可改善慢性 SCI 患者的骨矿物质密度和结构
  • 批准号:
    10418624
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI
Romosozumab 可改善慢性 SCI 患者的骨矿物质密度和结构
  • 批准号:
    10664874
  • 财政年份:
    2020
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了